Finally, lomerizine significantly inhibited tau phosphorylation in LPS-induced wild-type mice and AD neurons differentiated from induced pluripotent stem cells (iPSCs), potentially by reducing the LPS-stimulated activation of GSK3α/β and DYRK1A. Here, MAPT is linked to Alzheimer disease.